NCT06801002View on ClinicalTrials.gov

Trial to Evaluate the Safety & Tolerability of JBZ-001 in Pts With Advanced Solid and Hematological Malignancies

PHASE1RecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 17, 2025

Primary Completion Date

February 15, 2027

Study Completion Date

February 15, 2028

Conditions
Solid Tumor
Interventions
DRUG

JBZ-001

JBZ-001 Oral Capsule

Trial Locations (2)

43210

RECRUITING

The Ohio State University, Columbus

84119

RECRUITING

START Mountain Region, West Valley City

Sponsors
All Listed Sponsors
lead

Jabez Bioscience, Inc

INDUSTRY